Changing the cardiovascular prevention game
Results from a large clinical trial may mean a new era of super-low LDL targets and anti-inflammatory strategies.
Commentators on the presidential debates in the fall of 2008 were often asked whether they had spotted any "game changers" — something the candidates said or did that would alter the course of the election. A few days after Election Day, many doctors (especially cardiologists) were talking about a game changer in how we go about preventing heart attacks and strokes.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.